TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
ImmunoIVD AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
49,234
|
42,371
|
35,308 |
Financial expenses |
1,688
|
1,581
|
1,330 |
Earnings before taxes |
4,406
|
5,560
|
-2,827 |
EBITDA |
8,024
|
9,576
|
546 |
Total assets |
32,893
|
31,240
|
25,202 |
Current assets |
26,665
|
25,077
|
17,674 |
Current liabilities |
24,824
|
24,129
|
25,066 |
Equity capital |
8,069
|
7,111
|
136 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
25
|
23
|
26 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
24.5%
|
22.8%
|
0.5% |
Turnover per employee |
1,969
|
1,842
|
1,358 |
Profit as a percentage of turnover |
8.9%
|
13.1%
|
-8.0% |
Return on assets (ROA) |
18.5%
|
22.9%
|
-5.9% |
Current ratio |
107.4%
|
103.9%
|
70.5% |
Return on equity (ROE) |
54.6%
|
78.2%
|
-2078.7% |
Change turnover |
6,863
|
7,063
|
13,444 |
Change turnover % |
16%
|
20%
|
61% |
Chg. No. of employees |
2
|
-3
|
5 |
Chg. No. of employees % |
9%
|
-12%
|
24% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.